Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | FDP00595 | IM |
The patient took first dose of RabAvert in February and didn't receive second dose yet; Case reference number US-BN-2025-000898 is a spontaneous case initially received from a pharmacist via Med Communication (reference number: USBAV25-1009) on 02-May-2025 and concerns a 19-year-old, male patient. The patient's medical history and concomitant medication details were not provided. On 24-Feb-2025, the patient received the first dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: FDP00595) at unknown dose and site of administration, intramuscularly, for indication pre-exposure prophylaxis. The patient hadn't received the second dose yet (explicitly coded as 'incomplete course of vaccination'). At the time of initial report, it was unknown if the patient experienced any of adverse events due to RabaVert. No further information was provided.; Reporter's Comments: A 19-year-old male patient received the first dose of RabAvert in Feb 2025 for indication pre-exposure prophylaxis. The patient hadn't received the second dose yet, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any of adverse events due to RabaVert. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 19-year-old male patient received the first dose of RabAvert in Feb 2025 for indication pre-exposure prophylaxis. The patient hadn't received the second dose yet, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any of adverse events due to RabaVert. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE